Metis Global Partners LLC increased its position in AMETEK, Inc. (NYSE:AME – Free Report) by 7.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,168 shares of the technology company’s stock after buying an additional 1,324 shares during the quarter. Metis Global Partners LLC’s holdings in AMETEK were worth $3,120,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Family Firm Inc. bought a new stake in shares of AMETEK in the 2nd quarter worth approximately $39,000. Industrial Alliance Investment Management Inc. purchased a new stake in AMETEK during the second quarter valued at about $42,000. Headlands Technologies LLC bought a new position in shares of AMETEK during the first quarter valued at about $43,000. Princeton Global Asset Management LLC purchased a new position in shares of AMETEK in the third quarter worth about $44,000. Finally, Crewe Advisors LLC increased its holdings in shares of AMETEK by 168.8% in the second quarter. Crewe Advisors LLC now owns 293 shares of the technology company’s stock worth $49,000 after buying an additional 184 shares during the period. Hedge funds and other institutional investors own 87.43% of the company’s stock.
AMETEK Trading Down 0.8 %
AMETEK stock opened at $193.85 on Friday. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.39 and a quick ratio of 0.84. The stock has a market capitalization of $44.84 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 3.17 and a beta of 1.16. The business’s fifty day moving average is $172.43 and its 200 day moving average is $169.55. AMETEK, Inc. has a one year low of $149.03 and a one year high of $196.70.
AMETEK Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 0.58%. The ex-dividend date of this dividend is Friday, December 6th. AMETEK’s dividend payout ratio is presently 19.51%.
Insider Buying and Selling at AMETEK
In other news, Director Steven W. Kohlhagen sold 1,460 shares of the firm’s stock in a transaction on Wednesday, September 25th. The shares were sold at an average price of $171.59, for a total transaction of $250,521.40. Following the sale, the director now directly owns 23,349 shares in the company, valued at $4,006,454.91. This trade represents a 5.88 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider David F. Hermance sold 6,243 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $190.99, for a total transaction of $1,192,350.57. Following the completion of the transaction, the insider now directly owns 36,731 shares of the company’s stock, valued at $7,015,253.69. This represents a 14.53 % decrease in their position. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on the company. Robert W. Baird raised their price target on AMETEK from $166.00 to $186.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. StockNews.com upgraded AMETEK from a “hold” rating to a “buy” rating in a research report on Monday, November 4th. Redburn Atlantic upgraded shares of AMETEK to a “strong-buy” rating in a research report on Friday, August 2nd. Truist Financial increased their price objective on AMETEK from $219.00 to $221.00 and gave the stock a “buy” rating in a report on Friday, November 1st. Finally, Mizuho raised their target price on shares of AMETEK from $190.00 to $200.00 and gave the company an “outperform” rating in a research note on Friday, November 1st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, AMETEK currently has an average rating of “Moderate Buy” and a consensus price target of $197.86.
View Our Latest Stock Report on AME
AMETEK Company Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Further Reading
- Five stocks we like better than AMETEK
- Consumer Discretionary Stocks Explained
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Most Volatile Stocks, What Investors Need to Know
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.